日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Estrogen receptor β target gene expression reveals novel repressive functions in aggressive breast cancer

雌激素受体β靶基因表达揭示了其在侵袭性乳腺癌中的新型抑制功能

Tastsoglou, Spyros; Karagounis, Ilias V; Miliotis, Marios; Nagandla, Harika; Zambo, Kristina Diana A; Liousia, Maria; Ueno, Naoto; Maity, Amit; Hatzigeorgiou, Artemis G; Thomas, Christoforos

Nitric oxide-dependent stabilization of vimentin confers chemoresistance in ovarian cancer

一氧化氮依赖性波形蛋白稳定作用赋予卵巢癌化疗耐药性

Melone, Gianmarco; Bayraktar, Recep; Zhao, Hong; Hynes, Sean O; Kaar, Fidelma; Freegrove, Adam; Deng, Jenying; Baseviciene, Agne; Uzair, Ivonne; Martinez, Karina Ortega; Guzman-Rojas, Liliana; Chervo, Maria Florencia; Li, Mailin; Qian, Wei; Zhou, Jianying; Phillips, Aireana; Zambo, Kristina Diana A; Nikolos, Fotis; Chan, Keith S; Thomas, Christoforos; Francis, Lewis; Chang, Jenny C

Targeting LIPA with ERX-41 Induces ER Stress and Inhibits Tumor Progression in Inflammatory Breast Cancer

利用 ERX-41 靶向 LIPA 可诱导内质网应激并抑制炎性乳腺癌的肿瘤进展

Fuentes, Zenaida; Sharma, Gaurav; Romo, Bianca A; Gopalam, Rahul; Nassar, Khaled Mohamed; Ramirez, Paulina; Mejia, Nicole; Chen, Chia-Yuan; Elmore, Scott; Neal, Henry; Nagandla, Harika; Subbarayalu, Panneerdoss; Pratap, Uday P; Thomas, Christoforos; Ahn, Jung-Mo; Raj, Ganesh V; Viswanadhapalli, Suryavathi; Vadlamudi, Ratna K

Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis.

靶向白血病抑制因子/白血病抑制因子受体轴可通过促进铁死亡来减少炎症性乳腺癌的生长

Romo Bianca, Fuentes Zenaida, Randolph Lois, Mahajan Megharani, Aller Emily J, Ebrahimi Behnam, Santhamma Bindu, Pratap Uday P, Subbarayalu Panneerdoss, Nagandla Harika, Thomas Christoforos, Nair Hareesh B, Vadlamudi Ratna K, Viswanadhapalli Suryavathi

NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression.

NOS 抑制通过 c-JUN 抑制使化生性乳腺癌对 PI3K 抑制剂和紫杉烷类药物治疗更加敏感

Reddy Tejaswini, Puri Akshjot, Guzman-Rojas Liliana, Thomas Christoforos, Qian Wei, Zhou Jianying, Zhao Hong, Mahboubi Bijan, Oo Adrian, Cho Young-Jae, Kim Baek, Thaiparambil Jose, Rosato Roberto, Martinez Karina Ortega, Chervo Maria Florencia, Ayerbe Camila, Giese Noah, Wink David, Lockett Stephen, Wong Stephen, Chang Jeffrey, Krishnamurthy Savitri, Yam Clinton, Moulder Stacy, Piwnica-Worms Helen, Meric-Bernstam Funda, Chang Jenny

Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the Receptor

雌激素通过ERβ在乳腺癌中发出信号;自发现该受体以来我们所了解到的

Nagandla, Harika; Thomas, Christoforos

ERβ as a mediator of estrogen signaling in inflammatory breast cancer

ERβ作为炎症性乳腺癌中雌激素信号传导的介质

Nagandla, Harika; Thomas, Christoforos

ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function

ERβ通过调节p53功能改变管腔型乳腺癌细胞的化疗敏感性

Bado, Igor; Pham, Eric; Soibam, Benjamin; Nikolos, Fotis; Gustafsson, Jan-Åke; Thomas, Christoforos

Targeting PES1 for restoring the ERα/ERβ ratio in breast cancer

靶向PES1以恢复乳腺癌中ERα/ERβ的比例

Thomas, Christoforos; Gustafsson, Jan-Åke

ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR

ERβ1通过破坏EGFR的稳定性来抑制基底乳腺癌的上皮间质转化。

Thomas, Christoforos; Rajapaksa, Gayani; Nikolos, Fotis; Hao, Ruixin; Katchy, Anne; McCollum, Catherine W; Bondesson, Maria; Quinlan, Phil; Thompson, Alastair; Krishnamurthy, Savitri; Esteva, Francisco J; Gustafsson, Jan-Åke